The specific role of pRb in p16 (INK4A) -mediated arrest of normal and malignant human breast cells
- PMID: 22333593
- PMCID: PMC3323799
- DOI: 10.4161/cc.11.5.19492
The specific role of pRb in p16 (INK4A) -mediated arrest of normal and malignant human breast cells
Abstract
RB family proteins pRb, p107 and p130 have similar structures and overlapping functions, enabling cell cycle arrest and cellular senescence. pRb, but not p107 or p130, is frequently mutated in human malignancies. In human fibroblasts acutely exposed to oncogenic ras, pRb has a specific role in suppressing DNA replication, and p107 or p130 cannot compensate for the loss of this function; however, a second p53/p21-dependent checkpoint prevents escape from growth arrest. This model of oncogene-induced senescence requires the additional loss of p53/p21 to explain selection for preferential loss of pRb function in human malignancies. We asked whether similar rules apply to the role of pRb in growth arrest of human epithelial cells, the source of most cancers. In two malignant human breast cancer cell lines, we found that individual RB family proteins were sufficient for the establishment of p16-initiated senescence, and that growth arrest in G 1 was not dependent on the presence of functional pRb or p53. However, senescence induction by endogenous p16 was delayed in primary normal human mammary epithelial cells with reduced pRb but not with reduced p107 or p130. Thus, under these circumstances, despite the presence of functional p53, p107 and p130 were unable to completely compensate for pRb in mediating senescence induction. We propose that early inactivation of pRb in pre-malignant breast cells can, by itself, extend proliferative lifespan, allowing acquisition of additional changes necessary for malignant transformation.
Figures
Similar articles
-
Retinoblastoma family proteins have distinct functions in pulmonary epithelial cells in vivo critical for suppressing cell growth and tumorigenesis.Cancer Res. 2009 Nov 15;69(22):8733-41. doi: 10.1158/0008-5472.CAN-09-1359. Epub 2009 Nov 3. Cancer Res. 2009. PMID: 19887614 Free PMC article.
-
RB, p130 and p107 differentially repress G1/S and G2/M genes after p53 activation.Nucleic Acids Res. 2019 Dec 2;47(21):11197-11208. doi: 10.1093/nar/gkz961. Nucleic Acids Res. 2019. PMID: 31667499 Free PMC article.
-
Distinct roles for p107 and p130 in Rb-independent cellular senescence.Cell Cycle. 2008 May 1;7(9):1262-8. doi: 10.4161/cc.7.9.5945. Epub 2008 Mar 7. Cell Cycle. 2008. PMID: 18418057 Free PMC article.
-
Activity of the retinoblastoma family proteins, pRB, p107, and p130, during cellular proliferation and differentiation.Crit Rev Biochem Mol Biol. 1996 Jun;31(3):237-71. doi: 10.3109/10409239609106585. Crit Rev Biochem Mol Biol. 1996. PMID: 8817077 Review.
-
The Rb family connects with the Tp53 family in skin carcinogenesis.Mol Carcinog. 2007 Aug;46(8):618-23. doi: 10.1002/mc.20338. Mol Carcinog. 2007. PMID: 17486638 Review.
Cited by
-
Aberrant activation of p53/p66Shc-mInsc axis increases asymmetric divisions and attenuates proliferation of aged mammary stem cells.Cell Death Differ. 2022 Dec;29(12):2429-2444. doi: 10.1038/s41418-022-01029-5. Epub 2022 Jun 23. Cell Death Differ. 2022. PMID: 35739253 Free PMC article.
-
Inhibition of GSK-3β activity can result in drug and hormonal resistance and alter sensitivity to targeted therapy in MCF-7 breast cancer cells.Cell Cycle. 2014;13(5):820-33. doi: 10.4161/cc.27728. Epub 2014 Jan 9. Cell Cycle. 2014. PMID: 24407515 Free PMC article.
-
Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities for therapeutic intervention.Oncotarget. 2014 Jul 15;5(13):4603-50. doi: 10.18632/oncotarget.2209. Oncotarget. 2014. PMID: 25051360 Free PMC article. Review.
-
pRb or its cousins: who controls the family business?Cell Cycle. 2012 Apr 15;11(8):1486. doi: 10.4161/cc.20048. Cell Cycle. 2012. PMID: 22544076 Free PMC article.
-
A TORC2-Akt Feed-Forward Topology Underlies HER3 Resiliency in HER2-Amplified Cancers.Mol Cancer Ther. 2015 Dec;14(12):2805-17. doi: 10.1158/1535-7163.MCT-15-0403. Epub 2015 Oct 5. Mol Cancer Ther. 2015. PMID: 26438156 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous